Abstract Details
|
Pilar Pichon, MD
PRESENTER |
Dr. Pichon has stock in Merck. Dr. Pichon has stock in Boston Scientific. Dr. Pichon has stock in Fulcrum therapeutics. Dr. Pichon has stock in Bristol-Myers Squibb. Dr. Pichon has stock in CyromX. Dr. Pichon has stock in Recursion pharmaceuticals. Dr. Pichon has stock in America Well. Dr. Pichon has stock in NanoVicirides. Dr. Pichon has stock in Alzamend Neuro. Dr. Pichon has stock in Synaptogenix. Dr. Pichon has stock in Tyra Biosciences. Dr. Pichon has stock in Teladoc Health. Dr. Pichon has stock in Augmedix. Dr. Pichon has stock in Vaxxinity. Dr. Pichon has stock in Immunogen. Dr. Pichon has stock in Abbott. Dr. Pichon has stock in Roche. Dr. Pichon has stock in Vir Biotechnology. Dr. Pichon has stock in Altamira therapeutics. Dr. Pichon has stock in Talkspace. Dr. Pichon has stock in GE. Dr. Pichon has stock in GE Healthcare. Dr. Pichon has stock in Wolters Kluwer. Dr. Pichon has stock in Doximity. Dr. Pichon has stock in Coherus Biosciences. Dr. Pichon has stock in ABVC Biopharma Inc. Dr. Pichon has stock in AC Immune . Dr. Pichon has stock in Armata Pharmaceuticals. Dr. Pichon has stock in Atea Pharmaceuticals. Dr. Pichon has stock in Bellicum Pharmaceuticals. Dr. Pichon has stock in Evaxion Biotech. Dr. Pichon has stock in Geovax Labs. Dr. Pichon has stock in Atyr Pharma. Dr. Pichon has stock in Neurometrix. Dr. Pichon has stock in Novavax. Dr. Pichon has stock in PROQR Therapeutics. Dr. Pichon has stock in Avidity Biosciences. Dr. Pichon has stock in Surrozen. Dr. Pichon has stock in Takeda. Dr. Pichon has stock in Telesis Bio. Dr. Pichon has stock in Well Health Technologies. |
| No disclosure on file | |
| Paul Morgan | No disclosure on file |
| No disclosure on file | |
| Shafali Jeste, MD, FAAN (Children's Hospital of Los Angeles) | Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance. |
| No disclosure on file |